MedPath

The study to prevent and reduce postoperative nausea and vomiting due to continuous epidural administratio

Not Applicable
Conditions
patients scheduled for abdominal gynecological surgery under general-epidural anesthesia
Registration Number
JPRN-UMIN000017055
Lead Sponsor
Saiseikai Narashino Hospital
Brief Summary

The incidences rate of PONV were 27.9% (doropeidol group) and 58.1% (epinephrine group), respectively (P=0.0046, odds ratio 0.279, NNT 3.13). The use frequency of the antiemetics were 18.6% and 41.9%, respectively (P=0.0189, odds ratio 0.317, NNT 4.29). There was one patient who had to cancel continuous epidural administration for vomiting in epinephrine group, but no patient in doropeidol group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
84
Inclusion Criteria

Not provided

Exclusion Criteria

age<18, >=80, ASA-PS<=3, BMI<=35, QT prolongation, Parkinson's disease, psychiatric history, drug abuser, steroid administration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the incidences of PONV, the use frequency of the antiemetics
Secondary Outcome Measures
NameTimeMethod
the incidences of cancelling continuous epidural administration for vomiting, the use frequency of the adjuvant analgesic, the incidences of pruritus, the incidences of reduction in blood pressure
© Copyright 2025. All Rights Reserved by MedPath